Syngenta CEO Targets Seeds as Top M&A Priority

The transcript discusses Syngenta's merger with CHEM China, highlighting the strategic benefits and challenges of expanding in China. It covers increased R&D investments, innovation, and the importance of the Chinese market. The discussion also touches on competition with Bayer Monsanto, M&A strategies, and the role of leadership in navigating global trade relations, particularly amid US-China tensions.

What has been Syngenta's biggest opportunity since merging with CHEM China?

• Expanding in Europe

• Expanding in China

• Reducing R&D costs

• Focusing on digital technology

How much does Syngenta spend annually on R&D?

• $2 billion

• $1.4 billion

• $1 billion

• $500 million

What is one of the key areas Syngenta is focusing on to drive higher yields?

• Reducing labor costs

• Increasing pesticide use

• Expanding into new markets

• Addressing climate change

What is Syngenta's position in the seeds market?

• Leader

• Second

• Fourth

• Distant third

What is a top priority for Syngenta's acquisitions?

• Seeds

• Biological technologies

• Digital companies

• Pesticides

Who is the chairman of both Chem China and Syngenta?

• Jack Ma

• Tim Cook

• Frank Ning

• Elon Musk

What percentage of the world's arable land does China have?

• 10%

• 21%

• 15%

• 7%